{"id":5537,"date":"2018-06-30T13:40:00","date_gmt":"2018-06-30T13:40:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&p=5537"},"modified":"2024-05-02T11:19:58","modified_gmt":"2024-05-02T09:19:58","slug":"a-multicenter-retrospective-study-aiming-to-identify-patients-who-respond-well-to-adsorptive-granulomonocytapheresis-in-moderately-to-severely-active-ulcerative-colitis","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/fr\/professional\/scientific-corner\/a-multicenter-retrospective-study-aiming-to-identify-patients-who-respond-well-to-adsorptive-granulomonocytapheresis-in-moderately-to-severely-active-ulcerative-colitis\/","title":{"rendered":"A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis."},"content":{"rendered":"
\n

Takayuki Yamamoto<\/a> 1<\/a><\/sup>, Takayuki Iida<\/a> 2<\/a><\/sup>, Kentaro Ikeya<\/a> 2<\/a><\/sup>, Masaichi Kato<\/a> 2<\/a><\/sup>, Ai Matsuura<\/a> 2<\/a><\/sup>, Satoshi Tamura<\/a> 3<\/a><\/sup>, Ryosuke Takano<\/a> 3<\/a><\/sup>, Shinya Tani<\/a> 4<\/a><\/sup>, Satoshi Osawa<\/a> 4<\/a><\/sup>, Ken Sugimoto<\/a> 3<\/a><\/sup>, Takahiro Shimoyama<\/a> 5<\/a><\/sup>, Hiroyuki Hanai<\/a> 2<\/a><\/sup> , Clin Transl Gastroenterol 2018 Jul 6;9(7):170.<\/p>\n<\/div>\n\n

\n

Objectives: <\/strong>Adsorptive granulomonocytapheresis (GMA) with the Adacolumn has been introduced as a non-pharmacologic treatment for ulcerative colitis (UC). However, a subset of patients who might respond well to GMA needs to be targeted. This study was conducted at three IBD centers to determine factors affecting the efficacy of GMA in patients with moderately-to-severely active UC. 1234567890(); 1234567890(),; 1234567890(); 1234567890(); Methods: <\/strong>From January 2008 to December 2017, a total of 894 active episodes (first attack or relapse) in 593 patients were treated with GMA. Clinical remission was defined as normal stool frequency and no rectal bleeding. Multiple clinical and laboratory parameters at entry were considered for efficacy assessment. Results: <\/strong>Clinical remission was achieved during 422 (47%) of the 894 treatment cases. In the multivariate analysis, predictors for favorable response to GMA were age \u226460 years, UC duration <1 year, Mayo endoscopic subscore 2 (vs. 3), steroid na\u00efve UC, and biologic na\u00efve UC. Clinical remission rate was 70% in patients with four of the five factors, 52% in patients with three factors, 46% in patients with two factors, 39% in patients with one factor, and 18% in patients with none of these factors. Overall, the clinical remission rate was significantly higher in patients with a greater number of the five predictors (P < 0.0001). Conclusions: <\/strong>GMA appeared to be effective in steroid na\u00efve and biologic na\u00efve patients with short duration of UC. Elderly patients (>60 years) and those with severe endoscopic activity did not respond well to GMA. Additional, well designed, prospective, controlled trials should strengthen our findings.<\/p>\n<\/div>\n\n

\n

https:\/\/pubmed.ncbi.nlm.nih.gov\/29977035\/<\/a><\/p>\n<\/div>\n\n

\n

https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6033883\/pdf\/41424_2018_Article_37.pdf<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Takayuki Yamamoto 1, Takayuki Iida 2, Kentaro Ikeya 2, Masaichi Kato 2, Ai Matsuura 2, Satoshi Tamura 3, Ryosuke Takano 3, Shinya Tani 4, Satoshi Osawa 4, Ken Sugimoto 3, Takahiro Shimoyama 5, Hiroyuki Hanai 2 , Clin Transl Gastroenterol 2018 Jul 6;9(7):170. Objectives: Adsorptive granulomonocytapheresis (GMA) with the Adacolumn has been introduced as a non-pharmacologic treatment for ulcerative colitis (UC). However, a subset of patients who might respond well to GMA needs to be targeted. This study […]<\/p>\n","protected":false},"template":"","scientific_tags":[186,147,308,100,305,185,306],"class_list":["post-5537","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-biologics-naive","scientific_tags-clinical-remission","scientific_tags-mucosal-healing","scientific_tags-multicenter","scientific_tags-retrsopective","scientific_tags-steroid-naive","scientific_tags-ulcerative-colitis"],"acf":[],"yoast_head":"\nA multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis. - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/a-multicenter-retrospective-study-aiming-to-identify-patients-who-respond-well-to-adsorptive-granulomonocytapheresis-in-moderately-to-severely-active-ulcerative-colitis\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis. - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Takayuki Yamamoto 1, Takayuki Iida 2, Kentaro Ikeya 2, Masaichi Kato 2, Ai Matsuura 2, Satoshi Tamura 3, Ryosuke Takano 3, Shinya Tani 4, Satoshi Osawa 4, Ken Sugimoto 3, Takahiro Shimoyama 5, Hiroyuki Hanai 2 , Clin Transl Gastroenterol 2018 Jul 6;9(7):170. Objectives: Adsorptive granulomonocytapheresis (GMA) with the Adacolumn has been introduced as a non-pharmacologic treatment for ulcerative colitis (UC). However, a subset of patients who might respond well to GMA needs to be targeted. This study […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/a-multicenter-retrospective-study-aiming-to-identify-patients-who-respond-well-to-adsorptive-granulomonocytapheresis-in-moderately-to-severely-active-ulcerative-colitis\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-02T09:19:58+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/a-multicenter-retrospective-study-aiming-to-identify-patients-who-respond-well-to-adsorptive-granulomonocytapheresis-in-moderately-to-severely-active-ulcerative-colitis\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/a-multicenter-retrospective-study-aiming-to-identify-patients-who-respond-well-to-adsorptive-granulomonocytapheresis-in-moderately-to-severely-active-ulcerative-colitis\/\",\"name\":\"A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis. - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2018-06-30T13:40:00+00:00\",\"dateModified\":\"2024-05-02T09:19:58+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/a-multicenter-retrospective-study-aiming-to-identify-patients-who-respond-well-to-adsorptive-granulomonocytapheresis-in-moderately-to-severely-active-ulcerative-colitis\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis. - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/a-multicenter-retrospective-study-aiming-to-identify-patients-who-respond-well-to-adsorptive-granulomonocytapheresis-in-moderately-to-severely-active-ulcerative-colitis\/","og_locale":"fr_FR","og_type":"article","og_title":"A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis. - Adacyte","og_description":"Takayuki Yamamoto 1, Takayuki Iida 2, Kentaro Ikeya 2, Masaichi Kato 2, Ai Matsuura 2, Satoshi Tamura 3, Ryosuke Takano 3, Shinya Tani 4, Satoshi Osawa 4, Ken Sugimoto 3, Takahiro Shimoyama 5, Hiroyuki Hanai 2 , Clin Transl Gastroenterol 2018 Jul 6;9(7):170. Objectives: Adsorptive granulomonocytapheresis (GMA) with the Adacolumn has been introduced as a non-pharmacologic treatment for ulcerative colitis (UC). However, a subset of patients who might respond well to GMA needs to be targeted. This study […]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/a-multicenter-retrospective-study-aiming-to-identify-patients-who-respond-well-to-adsorptive-granulomonocytapheresis-in-moderately-to-severely-active-ulcerative-colitis\/","og_site_name":"Adacyte","article_modified_time":"2024-05-02T09:19:58+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/a-multicenter-retrospective-study-aiming-to-identify-patients-who-respond-well-to-adsorptive-granulomonocytapheresis-in-moderately-to-severely-active-ulcerative-colitis\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/a-multicenter-retrospective-study-aiming-to-identify-patients-who-respond-well-to-adsorptive-granulomonocytapheresis-in-moderately-to-severely-active-ulcerative-colitis\/","name":"A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis. - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2018-06-30T13:40:00+00:00","dateModified":"2024-05-02T09:19:58+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/a-multicenter-retrospective-study-aiming-to-identify-patients-who-respond-well-to-adsorptive-granulomonocytapheresis-in-moderately-to-severely-active-ulcerative-colitis\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific-corner\/5537","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/media?parent=5537"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/fr\/wp-json\/wp\/v2\/scientific_tags?post=5537"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}